Epernicus: Sarah E Henrickson, Ph.D.

Sarah E Henrickson, Ph.D.

Positions:
Medical Student

Harvard-MIT Division of Health Sciences and Technology (Cambridge, MA)

Post Doctoral Fellow

Pathology

Immune Disease Institute

Harvard Medical School (Boston, MA)
Advisor:
Ulrich H. von Andrian
Degrees:

Ph.D., Immunology, Harvard Medical School (Boston, MA)

A.B., Biochemistry, Harvard University (Cambridge, MA)
Past Advisors:

Louis M. Staudt (as Technician)

Hidde Ploegh (as Undergraduate Student)

John J. Kasianowicz (as Undergraduate Student)
Research:
The dynamics of T cell activation in vivo.
Other Experience:
2008-2009 Post Doctoral Fellow with Dr. von Andrian

2001-2002 Cancer Research Training Award Predoctoral Trainee at NIH

Communities:

Sarah Henrickson's Genealogy

The Adobe Flash Player plugin (version 8) is required to view the genealogy tree.
Download the plugin here.

Sarah Henrickson's Publications (17)

Probing single nanometer-scale pores with polymeric molecular rulers.
Henrickson SE, DiMarzio EA, Wang Q, Stanford VM, Kasianowicz JJ

The Journal of chemical physics. 2010 Apr 7;132(13):135101
Towards estimating the true duration of dendritic cell interactions with T cells.
Beltman JB, Henrickson SE, von Andrian UH, de Boer RJ, Marée AF

Journal of immunological methods. 2009 Aug 15;347(1-2):54-69
How antigen quantity and quality determine T-cell decisions in lymphoid tissue.
Zheng H, Jin B, Henrickson SE, Perelson AS, von Andrian UH, Chakraborty AK

Molecular and cellular biology. 2008 Jun;28(12):4040-51
T cell sensing of antigen dose governs interactive behavior with dendritic cells and sets a threshold for T cell activation.
Henrickson SE, Mempel TR, Mazo IB, Liu B, Artyomov MN, Zheng H, Peixoto A, Senman B, Junt T, Wong HC, Chakraborty AK, von Andrian UH

Nature immunology. 2008 Mar;9(3):282-91
In vivo imaging of T cell priming.
Henrickson SE, Mempel TR, Mazo IB, Liu B, Artyomov MN, Zheng H, Peixoto A, Senman B, Junt T, Wong HC, Chakraborty AK, von Andrian UH

Science signaling. 2008;1(12):pt2
Subcapsular sinus macrophages in lymph nodes clear lymph-borne viruses and present them to antiviral B cells.
Junt T, Moseman EA, Iannacone M, Massberg S, Lang PA, Boes M, Fink K, Henrickson SE, Shayakhmetov DM, Di Paolo NC, van Rooijen N, Mempel TR, Whelan SP, von Andrian UH

Nature. 2007 Nov 1;450(7166):110-4
Single-cell dynamics of T-cell priming.
Henrickson SE, von Andrian UH

Current opinion in immunology. 2007 Jun;19(3):249-58
Definition of germinal-center B cell migration in vivo reveals predominant intrazonal circulation patterns.
Hauser AE, Junt T, Mempel TR, Sneddon MW, Kleinstein SH, Henrickson SE, von Andrian UH, Shlomchik MJ, Haberman AM

Immunity. 2007 May;26(5):655-67
Gene expression profiling in malignant lymphomas.
Henrickson SE, Hartmann EM, Ott G, Rosenwald A

Advances in experimental medicine and biology. 2007;593:134-46
Differential gene expression in anaplastic lymphoma kinase-positive and anaplastic lymphoma kinase-negative anaplastic large cell lymphomas.
Thompson MA, Stumph J, Henrickson SE, Rosenwald A, Wang Q, Olson S, Brandt SJ, Roberts J, Zhang X, Shyr Y, Kinney MC

Human pathology. 2005 May;36(5):494-504
Role of NF-kappa B in cell survival and transcription of latent membrane protein 1-expressing or Epstein-Barr virus latency III-infected cells.
Cahir-McFarland ED, Carter K, Rosenwald A, Giltnane JM, Henrickson SE, Staudt LM, Kieff E

Journal of virology. 2004 Apr;78(8):4108-19
T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases.
Mempel TR, Henrickson SE, Von Andrian UH

Nature. 2004 Jan 8;427(6970):154-9
ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile.
Wiestner A, Rosenwald A, Barry TS, Wright G, Davis RE, Henrickson SE, Zhao H, Ibbotson RE, Orchard JA, Davis Z, Stetler-Stevenson M, Raffeld M, Arthur DC, Marti GE, Wilson WH, Hamblin TJ, Oscier DG, Staudt LM

Blood. 2003 Jun 15;101(12):4944-51
The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma.
Rosenwald A, Wright G, Wiestner A, Chan WC, Connors JM, Campo E, Gascoyne RD, Grogan TM, Muller-Hermelink HK, Smeland EB, Chiorazzi M, Giltnane JM, Hurt EM, Zhao H, Averett L, Henrickson S, Yang L, Powell J, Wilson WH, Jaffe ES, Simon R, Klausner RD, Montserrat E, Bosch F, Greiner TC, Weisenburger DD, Sanger WG, Dave BJ, Lynch JC, Vose J, Armitage JO, Fisher RI, Miller TP, LeBlanc M, Ott G, Kvaloy S, Holte H, Delabie J, Staudt LM

Cancer cell. 2003 Feb;3(2):185-97
Marine swimming-related illness: implications for monitoring and environmental policy.
Henrickson SE, Wong T, Allen P, Ford T, Epstein PR

Environmental health perspectives. 2001 Jul;109(7):645-50
Simultaneous multianalyte detection with a nanometer-scale pore.
Kasianowicz JJ, Henrickson SE, Weetall HH, Robertson B

Analytical chemistry. 2001 May 15;73(10):2268-72
Driven DNA transport into an asymmetric nanometer-scale pore.
Henrickson SE, Misakian M, Robertson B, Kasianowicz JJ

Physical review letters. 2000 Oct 2;85(14):3057-60

One Figure

T cells interact with dendritic cells in a lymph node in vivo.

Websites

Join Epernicus (membership is free)

Epernicus is open to current and former research scientists.

Already a member?
Sign in to view Sarah's full profile.

Sarah E Henrickson, Ph.D.

Medical Student

Post Doctoral Fellow

The dynamics of T cell activation in vivo.

Sarah Henrickson's Genealogy

Sarah Henrickson's Publications (17)

One Figure

Websites